Human Immunodeficiency Virus (HIV) Drugs Market Analysis with Competitive Landscape and Forecast 2025: Bristol-Myers Squibb, ViiV Healthcare, Gilead Sciences, Boehringer Ingelheim
Download PDF Brochure of Research Report: https://www.polarismarketresearch.com/industry-analysis/global-human-immunodeficiency-virus-hiv-drugs-market/request-for-free-sample
Human Immune-deficiency Virus (HIV) is the most extensive and incurable disease, causes HIV infection and over time Acquired Immunodeficiency Syndrome (AIDS). There has been a significant rise in number of HIV population worldwide. According to the World Health Organization (WHO) 2013, HIV ranked 6th among the global deaths throughout the world, with approximately 1,776,270 deaths in 2009. HIV is the 2nd most common cause of death after cancer. According to the same reports in 2009, more than 1,780,000 global death case were filed.
However, HIV antivirals is the largest segment of drug in the HIV infection market. Pharmaceutical companies are continuously focusing on the research and development for developing new drugs in the term to cure HIV infection by improving the person’s lifestyle supressing infection virus throughout the life.
Increasing R&D in the area of HIV infection and growing demand for the drugs bolstering the HIV drugs market.
In the recent time, rising prevalence of HIV infection is on the huge surge. According to the World Health Organizations (WHO) 2015, globally around 37 million number of people were found to be infected with HIV. Thus, rising incidence of HIV infected people and the demand for the drugs to treat the disease are the major factors driving the global market. Additionally, Rise in the incidence of unprotected sex has led to increase in the prevalence of HIV/AIDS, further demanding cure drugs.
Global Human Immunodeficiency Drugs (HIV) Market Taxonomy
The global Human Immunodeficiency (HIV) Drugs Market is segmented on the basis of Drug Class, Distribution channel, and geography.
On the basis of drug class, the global Human Immunodeficiency (HIV) drugs market is segmented into:
• Nucleoside reverse transcriptase inhibitors (NRTIs)
• Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs),
• Entry & Fusion Inhibitors
• Integrase Inhibitors
• Protease Inhibitors (PIs)
• Combination Class Drugs
On the basis of distribution channel, the global Human Immunodeficiency (HIV) drugs market is segmented into:
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
Complete Summary of this report @ https://www.polarismarketresearch.com/industry-analysis/global-human-immunodeficiency-virus-hiv-drugs-market/
Geographically, the global Human Immunodeficiency (HIV) drugs market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
Key players in global Human Immunodeficiency (HIV) drugs market:
• Bristol-Myers Squibb Company
• ViiV Healthcare (Pfizer Inc.)
• GlaxoSmithKline plc
• Gilead Sciences Inc.
• Boehringer Ingelheim (C.H. Boehringer Sohn AG & Ko. KG)
• Hoffmann-La Roche AG
• Abbott Laboratories Inc.
• Janssen Therapeutics
• Merck & Co. Inc.
• Cipla Limited
About us Polaris Market Research
Polaris Market Research is a global market research and consulting company. We provide unmatched quality of offerings to our clients present globally. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities.
Corporate Sales, USA
Polaris Market Research
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Human Immunodeficiency Virus (HIV) Drugs Market Analysis with Competitive Landscape and Forecast 2025: Bristol-Myers Squibb, ViiV Healthcare, Gilead Sciences, Boehringer Ingelheim here
News-ID: 1333391 • Views: 416
More Releases from Polaris Market Research & Consulting
What's driving the Blockchain Technology Market Trends? Microsoft Corporation, I …
The worldwide market size for blockchain technology is estimated to grow at a CAGR of 41.6% between 2018 and 2026 and is anticipated to reach USD 16.82 billion by 2026. According to a new study published by Polaris Market Research. Also termed as Distributed Ledger Technology (DLT), blockchain enables secure transaction over a distributed network. Since the transactions are taken place usually over the network, it is difficult to reverse
What's driving the Precision Farming Market Trends? Ag Leader Technology, AgJunc …
The global precision farming/agriculture market was valued at 3,833 million in 2017 and is anticipated to reach over USD 13,016 million by 2026 with grow at a CAGR of more than 14.7% during the forecast period According to a new study published by Polaris Market Research. In 2017, the yield monitoring application dominated the global market, in terms of revenue. North America is expected to be the leading contributor to
What are the different trends in Electric Vehicles (EV) Market to boost its grow …
Polaris Market Research has new report published the addition of the “The global Electric Vehicles Market Worth $912 Billion By 2026 | CAGR: 38.4%”, the report classifies the global Electric Vehicles market in a precise manner to offer unearth valuable, accurate and reliable data insights that help organizations to meet their business objectives and enable growth Get PDF Sample of “Electric Vehicles Market”: https://www.polarismarketresearch.com/industry-analysis/electric-vehicles-ev-market/request-for-sample The global electric vehicles market is anticipated to
What are the different trends in Third Party Logistics Market to boost its growt …
Polaris Market Research has new report published the addition of the “The global third-party logistics market is anticipated to reach USD 1,337.91 billion by 2026”, the report classifies the global third-party logistics market in a precise manner to offer unearth valuable, accurate and reliable data insights that help organizations to meet their business objectives and enable growth according to a new report The report “Third Party Logistics (3PL) Market Share, Size,
More Releases for HIV
Global HIV Market to 2024
The HIV market was valued at $16bn in 2015 and is forecast to expand at a CAGR of 3.7% between 2015 and 2024, culminating in 2024 global sales of $23bn.The expected arrival of new classes of therapies could result in a paradigm shift in the treatment of HIV treatment. Globally, around 35 million people are infected with HIV. Approximately 3 million people in the U.S and 2.5 million in top 5
HIV Vaccine Market HIV Vaccine Clinical Pipeline Report 2022
For Report Sample Contact: firstname.lastname@example.org or +91-11-47067990 Report Table of Contents Introduction to Human Immunodeficiency Virus (HIV) Vaccines 1.1 Overview 1.2 Antiquity of HIV Vaccine Need for the Development of HIV Vaccine Primer of HIV inside the Body 3.1 Inclusion of HIV Virus into the System 3.2 Interaction of HIV with Host 3.3 Eradication of HIV Virus HIV Vaccine Development Process 4.1 Introduction
Global HIV Vaccine Market & HIV Vaccine Clinical Trial Outlook 2022
Worldwide, around the 35 Million of the people are currently infected with the HIV and about 30 Million of the people died because of the AIDS infection. There is no human example of clearing an HIV infection naturally. HIV virus makes copies of it very quickly, many types of HIV exist and new types of virus are continue to rise. Many scientists are still trying to understand the specific ways
Global HIV Infection Pipeline Analysis
The discovery of HIV virus, which causes AIDS, dates back to more than 30 years. Currently, there are more than 30 drugs in the market which have been approved by the FDA for the treatment of HIV infection. Consequent to the introduction of retrovirals in 1996, HIV is not considered to be a death sentence anymore. The advancements in this field have led to new drugs being produced which have
Global HIV Therapeutics Market
The HIV Therapeutics Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. The human immunodeficiency virus (HIV) refers to a type of retrovirus that causes acquired immunodeficiency syndrome (AIDS). HIV attacks some immune cells and causes weakness of immune system resulting in loss
Hidden HIV Revealed: New Insights Into Latent HIV Infections
In spite of ever more effective therapies, HIV keeps managing to survive in the body. A comprehensive project conducted by the Austrian Science Fund FWF has clarified the molecular processes which contribute to this effect. In the process, approaches were discovered for possible therapies to combat the hidden reservoir formed by the virus. Thanks to modern therapies, HIV infections have become controllable – but these treatments cannot provide a cure. Antiretroviral